Efficacy and Safety of Lymphdiaral Basistropfen (HDC) in the Treatment of Chronic Low-back Pain
Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
To evaluate superiority of HDC in comparison to placebo in the treatment of chronic low-back
pain in relation to pain, functional impairment, quality of life, and state of health during
a 15-week treatment period.